Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-01

FDA Approved: PROVOCHOLINE — Supplemental Application (Methapharm Inc.)

View source ↗

Summary

FDA approved a supplemental application for Provocholine (methacholine chloride inhalation solution) submitted by Methapharm Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROVOCHOLINE (Methacholine chloride)

Snippet

SUPPL AP for PROVOCHOLINE (METHACHOLINE CHLORIDE)